微体代谢在甲诱导的细胞毒性中的作用
Jang Su Jeon1, Hyemin Kim2, Seongyea Jo2
1College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.
甲引起的药物诱导性肝损伤 (DILI) 与依赖UDP-glucuronosyltransferase (UGT) 的新陈代谢有关. 这一过程形成有毒的中间体,如甲酸乳,显著增加肝细胞损伤.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 药物诱导性肝损伤 (DILI) 是药物开发中的一个主要问题,导致市场退出.
- 由于DILI,已被撤销的NSAID Bromfenac已被撤销,但其代谢激活途径尚不清楚.
研究的目的:
- 为了阐明fenac诱导的肝损伤 (DILI) 的机制.
- 调查UDP-glucuronosyltransferase (UGT) 依赖代谢在甲肝毒性中的作用.
主要方法:
- 使用了HepG2细胞,人类肝脏显微体和UDP-葡萄糖酸 (UDPGA).
- 使用重组UGTs调查的UGT酶参与.
- 识别的代谢物和评估的甲及其代谢物的细胞毒性.
主要成果:
- UDPGA显著增加了fenac诱导的细胞毒性,突出了依赖于UGT的代谢.
- UGT2B7被确定为甲代谢激活中的关键酶.
- 作为一种反应性中间体的甲酸乳,其毒性比甲酸高出34倍,其毒性通过依赖NADPH的新陈代谢得到缓解.
结论:
- 依赖于UGT的新陈代谢,特别是通过UGT2B7,产生反应性代谢物,导致甲的肝毒性.
- 甲酸乳酸是甲酸引起的肝损伤的关键调解剂.
- 了解这些代谢途径对于预测和预防DILI至关重要.
更多相关视频
08:22Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
Published on: December 22, 2023
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
相关概念视频
Drug Metabolism: Phase II Reactions
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Drug Metabolism: Phase I Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
